What Is a Mosaic Embryo? Meaning, Transfer Success & Risks (2026)

What a mosaic embryo means in plain language: low-level vs high-level mosaicism, transfer success rates, birth defect risk, self-correction, and how to decide whether to transfer.

A mosaic embryo is an embryo that contains a mixture of chromosomally normal cells and chromosomally abnormal cells. It's neither clearly 'normal' (euploid) nor clearly 'abnormal' (aneuploid)—it sits in a complex middle ground that PGT-A genetic testing has only recently been able to detect. About 10–20% of tested embryos come back as mosaic. For years, clinics discarded them by default. We now know some mosaic embryos can self-correct during development and lead to healthy babies. This guide explains what mosaicism means in plain language, what causes it, how low-level and high-level mosaic embryos differ, what the real success and birth-defect data show, and how patients and clinicians approach the decision to transfer.

What Is a Mosaic Embryo? (Meaning in Plain Language)

A mosaic embryo contains two or more cell lines with different chromosome counts—some cells are euploid (normal number of chromosomes) and some are aneuploid (extra or missing chromosomes). Imagine a small mosaic tile pattern: most tiles are one color, but a few are different. In embryos, the 'color' is the chromosome makeup of each cell. A PGT-A biopsy samples a handful of cells from the trophectoderm (the outer layer that becomes the placenta) and reports the percentage of abnormal cells found in that sample.

  • Euploid embryo: all sampled cells are chromosomally normal
  • Mosaic embryo: a mix of normal and abnormal cells (roughly 20–80% abnormal)
  • Aneuploid embryo: nearly all sampled cells are abnormal (over 80%)
  • The biopsy only samples a few cells, so the result is a probability, not a certainty

Mosaic embryo meaning in one sentence: an embryo whose cells are not all genetically identical, where some cells have an abnormal chromosome count and others are normal.

What Causes Mosaic Embryos?

Mosaicism is caused by errors in cell division that happen after fertilization, while the embryo is dividing from one cell into many. The egg and sperm themselves are chromosomally normal, but as the embryo grows, one cell may divide incorrectly—producing daughter cells with extra or missing chromosomes. From that point on, the embryo contains both normal and abnormal cell lines.

  • Mitotic errors: mistakes during cell division in the early embryo (most common cause)
  • Anaphase lag: a chromosome fails to migrate properly during division
  • Nondisjunction: chromosomes don't separate evenly between daughter cells
  • Lab and culture conditions may play a minor role, but cannot reliably be controlled
  • Maternal age has a weaker link to mosaicism than to full aneuploidy

Mosaicism is not caused by anything the patient did or didn't do. It's a random event during early cell division and is not predictable or preventable.

Low-Level vs High-Level Mosaic Embryos

The single most important number on a mosaic PGT-A report is the percentage of abnormal cells. Clinicians group mosaic embryos into low-level and high-level categories because outcomes differ meaningfully between them.

  • Low-level mosaic embryo: roughly 20–40% abnormal cells. Best prognosis. Many embryologists rank these just below euploid embryos for transfer priority when no euploid is available.
  • High-level mosaic embryo: roughly 40–80% abnormal cells. Lower implantation and live-birth rates, and a higher miscarriage rate, than low-level mosaics.
  • Chromosome identity matters as much as level: low-level mosaicism for a 'minor' chromosome may be safer than low-level mosaicism for chromosomes 13, 18, or 21
  • Single-chromosome mosaicism is generally more favorable than mosaicism affecting multiple chromosomes
  • Segmental mosaics (partial chromosome changes) often have a better prognosis than whole-chromosome mosaics

If your report says 'low-level mosaic, single chromosome', that is the most favorable category. If it says 'high-level mosaic, multiple chromosomes', that's the most cautious category. Always review the specific chromosomes with a genetic counselor.

Can Mosaic Embryos Self-Correct?

Yes—this is one of the most important findings in modern reproductive genetics. Some mosaic embryos appear to eliminate or out-compete their abnormal cells during development, resulting in a chromosomally normal baby. This is why mosaic embryo transfers can succeed at all.

  • Abnormal cells often divide more slowly and get out-competed by normal cells
  • Abnormal cells may be preferentially allocated to the placenta (trophectoderm) rather than the fetus (inner cell mass)
  • Apoptosis (programmed cell death) can clear abnormal cells from the developing embryo
  • Because PGT-A biopsies the trophectoderm, the result may overstate the abnormality of the future baby
  • Self-correction is more commonly observed for low-level mosaics than for high-level mosaics

Mosaic Embryo Transfer Success Rates

Mosaic embryo transfers can and do result in healthy pregnancies. Reported success rates vary by study and by the specific mosaic profile, but the overall pattern is consistent: outcomes are lower than for euploid embryos, but meaningfully better than zero.

  • Implantation rates after mosaic transfer: roughly 30–50% (vs ~50–65% for euploid)
  • Live-birth rates after mosaic transfer: roughly 25–45% (vs ~45–60% for euploid)
  • Miscarriage rates after mosaic transfer: roughly 15–25% (vs ~10–15% for euploid)
  • Low-level mosaics perform much closer to euploid embryos than high-level mosaics do
  • Babies born from mosaic transfers are overwhelmingly chromosomally normal at birth

Mosaic embryo success stories are real and increasingly common. Patient registries (such as the PGDIS mosaic transfer registry) have documented hundreds of healthy live births from carefully selected mosaic embryo transfers.

Are Mosaic Embryos Viable? Risk of Birth Defects

The honest answer: most babies born from mosaic embryo transfers are chromosomally normal and healthy. However, the risk of an ongoing chromosomal abnormality in the baby is not zero, which is why additional prenatal testing is recommended after any mosaic transfer.

  • The vast majority of pregnancies from mosaic transfers result in chromosomally normal babies
  • Persistent mosaicism in the baby is uncommon but has been reported
  • Confined placental mosaicism (abnormal cells only in the placenta, normal baby) is more common
  • Mosaicism involving chromosomes 13, 18, or 21 carries the highest risk of a live-born syndrome and is generally avoided
  • Amniocentesis or CVS during pregnancy is the standard recommendation to confirm fetal chromosome status

If you are pregnant from a mosaic embryo transfer, prenatal diagnostic testing (CVS or amniocentesis) is strongly recommended. Routine non-invasive prenatal testing (NIPT) is not sufficient on its own.

Understanding Your Mosaic PGT-A Report

Mosaic results are reported with specific information that affects your decision. Knowing how to read the report helps you have a more productive conversation with your physician and genetic counselor.

  • Chromosome(s) affected: which chromosome carries the abnormality matters as much as the level
  • Level of mosaicism: lower percentages of abnormal cells have better prognosis
  • Whole-chromosome vs segmental: segmental (partial) mosaicism often carries lower risk
  • Type of imbalance: monosomy (missing) vs trisomy (extra) carry different implications
  • Single vs multiple chromosomes: multi-chromosomal mosaicism is the most cautious category

Which Mosaic Embryos Are Prioritized for Transfer?

Medical societies (PGDIS, ASRM) have published guidance on ranking mosaic embryos by risk when no euploid embryo is available. The ranking is not absolute—it is a starting point for individualized discussion.

  • Lowest risk: low-level mosaicism, single chromosome, segmental, chromosomes with low live-birth syndrome risk
  • Moderate risk: moderate mosaicism, single chromosome, chromosomes with milder phenotypes
  • Higher risk: high-level mosaicism, multiple chromosomes, or chromosomes linked to known syndromes
  • Generally avoided: mosaicism involving chromosomes 13 (Patau), 18 (Edwards), or 21 (Down syndrome) because they can result in a live-born syndrome
  • Also avoided: high-level mosaicism on chromosomes associated with uniparental disomy risk

The Decision: Should You Transfer a Mosaic Embryo?

There is no universally right answer. The decision belongs to you, your partner, your reproductive endocrinologist, and a certified genetic counselor. The honest factors that drive most decisions are listed below.

  • Do you have any euploid embryos available? (If yes, transfer those first.)
  • What is the specific mosaic profile—level, chromosome(s), segmental vs whole?
  • What is your age, ovarian reserve, and likelihood of another successful cycle?
  • Are you comfortable with additional prenatal testing during pregnancy?
  • What is your personal tolerance for uncertainty?
  • Have you considered alternatives—another IVF cycle, donor gametes, or not transferring?

Many patients feel pressure to 'try anything'. It is okay to take time. A good genetic counselor will help you understand risks honestly without pressuring you in either direction.

Key takeaways

  • A mosaic embryo contains both chromosomally normal and abnormal cells
  • 10–20% of PGT-A tested embryos are reported as mosaic
  • Mosaicism is caused by random cell-division errors after fertilization, not by anything the patient did
  • Low-level mosaic embryos (20–40% abnormal cells) have a much better prognosis than high-level (40–80%)
  • Some mosaic embryos self-correct during development and result in chromosomally normal babies
  • Live-birth rates for mosaic transfers are roughly 25–45%, lower than euploid but far from zero
  • Most babies born from mosaic transfers are chromosomally normal and healthy
  • Prenatal testing (CVS or amniocentesis) is recommended after any mosaic embryo transfer
  • Mosaicism involving chromosomes 13, 18, or 21 is generally avoided due to live-born syndrome risk
  • Genetic counseling is essential before deciding whether to transfer a mosaic embryo

Frequently asked questions

What is a mosaic embryo in simple terms?

A mosaic embryo is an embryo whose cells are not all genetically identical—some cells have a normal number of chromosomes, and some have an abnormal number. It sits between a fully normal (euploid) embryo and a fully abnormal (aneuploid) one. Mosaic embryos can sometimes self-correct during development and result in healthy babies.

What causes mosaic embryos?

Mosaicism is caused by errors in cell division that occur after fertilization, while the embryo is dividing from one cell into many. The egg and sperm are chromosomally normal at the start; the error happens during early growth. It is random, not predictable, and is not caused by anything the patient did or didn't do.

What is the difference between a low-level and high-level mosaic embryo?

Low-level mosaic embryos have roughly 20–40% abnormal cells, while high-level mosaic embryos have roughly 40–80%. Low-level mosaics have meaningfully better implantation and live-birth rates and lower miscarriage rates than high-level mosaics. When clinicians rank mosaic embryos for transfer priority, low-level single-chromosome mosaics rank highest.

Are mosaic embryos viable? Can they result in a healthy baby?

Yes. Many mosaic embryos are viable, and the majority of babies born from mosaic embryo transfers are chromosomally normal and healthy. This is because some mosaic embryos appear to self-correct during development, eliminating the abnormal cell line. Outcomes depend heavily on the specific mosaic profile.

Can mosaic embryos correct themselves?

Yes. Several mechanisms allow mosaic embryos to self-correct: abnormal cells often divide more slowly and get out-competed by normal cells; abnormal cells may be preferentially allocated to the placenta rather than the fetus; and programmed cell death can eliminate abnormal cells. Self-correction is more commonly observed for low-level mosaics than for high-level mosaics.

Do mosaic embryos cause birth defects?

The risk is low but not zero. The majority of pregnancies from mosaic transfers result in chromosomally normal babies, especially for low-level mosaics on lower-risk chromosomes. However, persistent mosaicism or full aneuploidy in the baby has been reported, which is why prenatal diagnostic testing (CVS or amniocentesis) is recommended after any mosaic transfer.

What is the success rate of a mosaic embryo transfer?

Reported success rates vary, but typical ranges are: implantation 30–50%, live birth 25–45%, miscarriage 15–25%. Outcomes are lower than for euploid embryos (live birth ~45–60%) but meaningfully better than zero. Low-level single-chromosome mosaics perform closer to euploid embryos than high-level multi-chromosome mosaics do.

Should I transfer a mosaic embryo?

It depends on the specific mosaic profile (level, chromosomes affected), whether euploid embryos are available, your age and prognosis, and your personal comfort with uncertainty. Many patients with no euploid embryos available choose to transfer carefully selected low-level mosaics and have had healthy pregnancies. Genetic counseling is essential before deciding.

Has anyone successfully transferred a mosaic embryo?

Yes—hundreds of healthy live births from mosaic embryo transfers have been documented in international registries (such as the PGDIS mosaic transfer registry). Mosaic embryo success stories are increasingly common as clinics gain experience and ranking guidelines have improved.

Should I discard my mosaic embryos?

Most experts now recommend keeping mosaic embryos in storage rather than discarding them. Even if you choose not to transfer them now, future research may provide better guidance, or your circumstances may change. Storage costs are typically modest compared to the cost of another IVF cycle.

Does mosaicism on chromosomes 13, 18, or 21 change the recommendation?

Yes. Mosaicism involving chromosomes 13 (Patau syndrome), 18 (Edwards syndrome), or 21 (Down syndrome) carries the highest risk of a live-born syndrome and is generally avoided for transfer, even at low levels. Mosaicism on other chromosomes is often more compatible with a healthy outcome.

Is prenatal testing required after a mosaic embryo transfer?

It is strongly recommended. Standard non-invasive prenatal testing (NIPT) alone is not sufficient. Diagnostic testing—CVS at around 10–13 weeks or amniocentesis at around 15–20 weeks—is the standard recommendation to confirm fetal chromosome status.